Trials / Completed
CompletedNCT03469596
Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Fondation Hôpital Saint-Joseph · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MRI sequence | several MRI sequence before and after contrast product injection. |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2017-05-01
- Completion
- 2017-12-31
- First posted
- 2018-03-19
- Last updated
- 2018-03-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03469596. Inclusion in this directory is not an endorsement.